A poster presented at ENDO 2021 appears to show promise for a new treatment aimed at patients with Cushing’s syndrome. The poster, presented by Strongbridge Biopharma, plc, a global commercial-stage biopharmaceutical company, announced that detailed results from the previously reported Phase 3 LOGICS study of RECORLEV® (levoketoconazole) in patients with endogenous Cushing’s syndrome were presented...
At ENDO 2021, the first time the Endocrine Society’s annual conference has gone all-virtual, a live Presidential Plenary on March 20 will feature a pair of presentations on the latest developments in basic tissue engineering. Nobel Prize winner Brian Kobilka, MD, talks to Endocrine News about his session, “Structural Insights into G Protein-Coupled Receptor Activation:...
A relatively new field, transgender medicine will be featured in the ENDO 2021 session, “Transgender Care: A Comprehensive Assessment for a Multi-Faceted Condition,” a live, 90-minute program taking place Sunday, March 21, 2021, at 12:15 p.m. Program co-chair, Stephen M. Rosenthal, MD, and Sabine Hannema, MD, PhD, talk to Endocrine News about what attendees can...
One of the most exciting components of the Endocrine Society’s annual conference is the shear amount of cutting-edge research presented by endocrinology researchers from around the world. ENDO 2021, the very first all-virtual annual conference, is certainly no different in that regard. Studies that could possibly lead to new therapies for a variety of endocrine...
At ENDO 2021, the first time the Endocrine Society’s annual conference will be presented virtually, attendees can tune into the live session “Ice Ice Baby: Fertility Preservation and Restoration” to learn about the scientific advances that are enabling young cancer survivors to have genetic children. Endocrine News talks to Mary B. Zelinski, PhD, and Ina...
At ENDO 2021, the first time the Endocrine Society’s annual conference has gone all-virtual, a live Presidential Plenary on March 20 will feature a pair of presentations on the latest developments in basic tissue engineering. Endocrine News speaks with Andrés J. Garcia, PhD, about his session, “Synthetic Hydrogels as Engineered Niches in Regenerative Medicine.” ...
One of the biggest obstacles to medical research is the lack of a truly representative population in clinical trials. For his ENDO Online 2020 session, “Minority Participation in Research: Considerations of Urgency and Strategy,” James R. Gavin III, MD, PhD, will discuss needed steps researchers can take to ensure clinical trials are representative of all...
When the Endocrine Society launches ENDO Online 2020 in June, attendees will be treated to Mirjam Christ-Crain, MD, PhD, from the University of Basel, Switzerland, who will discuss the top pituitary research studies in her session, “The Year in Pituitary: Clinical and Research Breakthroughs.” For such a miniscule structure, the pea-sized hypophysis plays an outsized...
At ENDO 2021, the first time the Endocrine Society’s annual conference has gone all-virtual, a live Presidential Plenary on March 20 will feature a pair of presentations on the latest developments in basic tissue engineering. Nobel Prize winner Brian Kobilka, MD, talks to Endocrine News about his session, “Structural Insights into G Protein-Coupled Receptor Activation:...
At ENDO 2021, the first time the Endocrine Society’s annual conference has gone all-virtual, a live Presidential Plenary on March 20 will feature a pair of presentations on the latest developments in basic tissue engineering. Endocrine News speaks with Andrés J. Garcia, PhD, about his session, “Synthetic Hydrogels as Engineered Niches in Regenerative Medicine.” ...
One of the biggest obstacles to medical research is the lack of a truly representative population in clinical trials. For his ENDO Online 2020 session, “Minority Participation in Research: Considerations of Urgency and Strategy,” James R. Gavin III, MD, PhD, will discuss needed steps researchers can take to ensure clinical trials are representative of all...
